The natural antibiotic Lugdunin, discovered three years ago by Tübingen DZIF researchers, attacks pathogenic bacteria in several different ways simultaneously and also interacts with the defense
Researchers have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model. The team showed in its publication, that T-cell therapy can provide a
Looking for an effective treatment of serious influenza infections, researchers of the Paul-Ehrlich-Institut have used bioinformatics to screen licensed medicines for their potential efficacy against
A research team from the Universities of Tübingen and Göttingen as well as from the German Center for Infection Research has investigated the mode of action of a new class of antibiotics that is
Helicobacter pylori, a globally distributed gastric bacterium, is genetically highly adaptable. The DZIF team of Professor Sebastian Suerbaum at LMU has now characterized its population structure in
The Zika virus outbreak in Latin America has affected over 60 million people up to now. The infection can have potentially fatal consequences for pregnant women and their unborn children: many
Salmonellainfections can have serious consequences for certain high-risk groups, such as young children, the elderly and individuals whose immune systems are functionally compromised.Most people
Some bacteria have a protective shell of cross-linked sugar molecules, which among other things, can ward off certain antibiotics. Researchers at the University of Bonn and the German Centre for
The largest trial on the treatment of aggressive hepatitis D (delta) worldwide was conducted at the German Liver Foundation’s HepNet Study House. It shows that an extension of treatment duration has
This year, the Memento Research Award for neglected diseases goes to Professor Jürgen May from the Bernhard Nocht Institute for Tropical Medicine (BNITM) in Hamburg. The jury honours his longstanding
